S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon

Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume

$1.31
-0.01 (-0.76%)
(As of 04/19/2024 ET)

Clearside Biomedical Short Interest Data

Current Short Volume
224,300 shares
Previous Short Volume
339,900 shares
Change Vs. Previous Month
-34.01%
Dollar Volume Sold Short
$343,179.00
Short Interest Ratio / Days to Cover
0.6
Last Record Date
March 31, 2024
Outstanding Shares
74,720,000 shares
Percentage of Shares Shorted
0.30%
Today's Trading Volume
228,503 shares
Average Trading Volume
297,038 shares
Today's Volume Vs. Average
77%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Clearside Biomedical ?

Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLSD Short Interest Over Time

CLSD Days to Cover Over Time

CLSD Percentage of Float Shorted Over Time

Clearside Biomedical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53
3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71
2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40
2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22
1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25
1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45
12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17
12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03
11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01
11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96
10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72
10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86
9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87
9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83
8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91
8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99
7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17
7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20
6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12
6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40
5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08
5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07
4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01
4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10
3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04
3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98
2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24
2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34
1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41
1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57
12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12
12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21
11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21
11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41
10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14
10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14
9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13
9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32
8/31/2022468,600 shares $641,982.00 +8.3%1.0%3.1 $1.37
8/15/2022432,700 shares $666,358.00 -7.0%0.9%2.8 $1.54
At first glance, this chart looks like nonsense… (Ad)

We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”

But if you want the stock with “Hotspot Dates” hitting NEXT WEEK…

CLSD Short Interest - Frequently Asked Questions

What is Clearside Biomedical's current short interest?

Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 224,300 shares of CLSD short. Learn More on Clearside Biomedical's current short interest.

What is a good short interest ratio for Clearside Biomedical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 1.0. Learn More on Clearside Biomedical's short interest ratio.

Which institutional investors are shorting Clearside Biomedical?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Clearside Biomedical's short interest increasing or decreasing?

Clearside Biomedical saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 224,300 shares, a decrease of 34.0% from the previous total of 339,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Clearside Biomedical's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Clearside Biomedical: Aclaris Therapeutics, Inc. (6.89%), PMV Pharmaceuticals, Inc. (6.40%), Chimerix, Inc. (1.56%), BioXcel Therapeutics, Inc. (10.54%), Eton Pharmaceuticals, Inc. (0.98%), DiaMedica Therapeutics Inc. (0.53%), Oncolytics Biotech Inc. (1.23%), Affimed (1.51%), Hookipa Pharma Inc (0.45%), Allakos Inc. (6.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Clearside Biomedical stock?

Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Clearside Biomedical?

A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further.

How often is Clearside Biomedical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CLSD) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners